Mesalamine Capsule, Extended Release
NDC 59651-397
Product Information
Mesalamine is a ANDA-approved product labeled by Aurobindo Pharma Limited. This medication is used to treat a certain bowel disease (ulcerative colitis). It is supplied as a blue capsule, extended release for oral administration. This product entry covers the primary NDC 59651-397 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
MSM;375
Code Structure Chart
Product Details
What is NDC 59651-397?
What are the uses of this product?
What are Active Ingredients of this product?
- MESALAMINE .375 g/1 - An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MESALAMINE (UNII: 4Q81I59GXC)
- MESALAMINE (UNII: 4Q81I59GXC) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- HYPROMELLOSE 2208 (100 MPA.S) (UNII: B1QE5P712K)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) (UNII: 74G4R6TH13)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- MICROCRYSTALLINE CELLULOSE 101 (UNII: 7T9FYH5QMK)
- NONOXYNOL-100 (UNII: A906T4D368)
- ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION (2:1; 750000 MW 30% AQUEOUS) (UNII: 8NT5GK8OOD)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- D&C RED NO. 22 (UNII: 1678RKX8RT)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)
- SHELLAC (UNII: 46N107B71O)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 825130 - mesalamine 0.375 GM 24HR Extended Release Oral Capsule
- RxCUI: 825130 - 24 HR mesalamine 375 MG Extended Release Oral Capsule
- RxCUI: 825130 - mesalamine 375 MG 24 HR Extended Release Oral Capsule
- RxCUI: 825130 - mesalazine 375 MG 24 HR Extended Release Oral Capsule
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.